Continuous MONItoring of Blood LActate and Glucose Levels Using a New Central Veinous Microdialysis Catheter Device

Monitorage Continu du Lactate et de la glycémie Par Microdialyse : Une étude de Validation en Chirurgie Cardiaque.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02296593

Acronym

MONILAG

Enrollment

Registered

2014-11-20

Start date

2014-11-30

Completion date

2016-11-30

Last updated

2017-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other Functional Disturbances Following Cardiac Surgery

Keywords

lactate, continuous lactate monitoring, continuous blood glucose monitoring, EIRUS, blood glucose, cardiac surgery, central veinous catheter, microdialysis

Brief summary

Continuous lactate and glucose blood levels

Detailed description

MAQUET Group offers a new device that gives real time blood lactate and glucose levels. It is a new central veinous catheter with a microdialysis system. It is planted in the superior vena cava. It has not yet been used and validated with a clinical purpose, and particularly in cardiac surgery. For now, reference method for determining blood lactate and glucose levels is co oxymetry. This new simple device could provide great fluency for determining blood lactate and glucose levels. It could allow medical teams gain time for diagnosis and treatment of both hyperlactatemia and hyperglycemia. The primary outcome of this study was to compare blood lactate and glucose absolute measures provided with the MAQUET new device (Maquet Critical Care AB, Solna, Sweden) and with co oxymetry. The secondary outcome of this study was to compare variations of these absolutes measures.

Interventions

DEVICEcomparison of blood lactate and glucose levels

comparison of blood lactate and glucose levels with the reference method (co oxymetry) and a new central veinous catheter microdialysis system provided by MAQUET. (Critical Care AB, Solna, Sweden.)

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Men or women more than 18 years old. * Cardiac surgery. * Central veinous catheter in superior vena cava.

Exclusion criteria

* Men or women less than 18 years old. * Pregnant women. * Central veinous catheter not in superior vena cava.

Design outcomes

Primary

Measure	Time frame	Description
comparison of absolute blood lactate and glucose levels with the reference method (co oxymetry) and a new method using a device providing real time measures of lactate and glycemia with a central veinous catheter microdialysis system.	1 day	Central veinous catheter, EIRUS (Maquet Critical Care AB, Solna, Sweden)

Secondary

Measure	Time frame	Description
comparison of variations of blood lactate and glycemia levels with the reference method (co oxymetry) and a new method using a device providing real time measures of lactate and glycemia. (EIRUS) with a central veinous catheter microdialysis system.	1 day	Central veinous catheter, EIRUS (Maquet Critical Care AB, Solna, Sweden)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026